What is Counterfeit stock:"Illegal naked shorting and stock manipulation are two of Wall Street's deep, dark secrets. These practices have been around for decades and have resulted in trillions of dollars being fleeced from the American public by Wall Street. In the process, many emerging companies have been put out of business. This report will explain the magnitude of this problem, how it happens, why it has been covered up and how short sellers attack a company."
http://counterfeitingstock.com/CS2.0/CounterfeitingStock.html
Anatomy Of A Short Attack:Abusive shorting are not random acts of a renegade hedge funds, but rather a coordinated business plan that is carried out by a collusive consortium of hedge funds and prime brokers, with help from their friends at the DTC and major clearinghouses. Potential target companies are identified, analyzed and prioritized. The attack is planned to its most minute detail.
The plan consists of taking a large short position, then crushing the stock price, and, if possible, putting the company into bankruptcy. Bankrupting the company is a short homerun because they never have to buy real shares to cover and they don't pay taxes on the ill-gotten gain.
When it is time to drive the stock price down, a blitzkrieg is unleashed against the company by a cabal of short hedge funds and prime brokers. The playbook is very similar from attack to attack, and the participating prime brokers and lead shorts are fairly consistent as well.
Citronresearch Short attack on CytoDyn FEB2020:
"CytoDyn has seen a wild ride in recent days spiking to highs of $10.01 per share on Teusday before the Andrew Left/Citron Short attack pummelled the stock to mid $4 lows. This has been followed by a solid comeback as CYDY has formed a new base over $6 per share. Andrew Lefts short attack has no bearing whatsoever on the overal promise of leronlimab and its effectiveness fighting covid-19"
https://www.newsmax.com/health/health-news/leronlimab-covid-stage-2/2020/11/20/id/998078/Newsmax NOV2020: New Blockbuster Drug Treatment for COVID-19 Patients Saves Lives, Study Shows
In a recent study at UCLA centers at Westwood and Santa Monica, Leronlimab, a monoclonal antibody blocker, was given to severely ill COVID-19 patients as an open label compassionate use therapy. The researchers concluded that the drug was safe and effective, according to the Infectious Diseases Society of America.
https://www.manilatimes.net/2021/02/01/public-square/vyrologix-shows-impressive-results-in-covid-19-patients/835690/Manilatimes FEB2021: CYTODYN, with drug leronlimab- Vyrologix, showed impressive results in improving the immune function of critically ill Covid-19 patients in the US... has already completed its Phase 2 clinical trial for Covid-19, a double-blinded, randomized clinical trial for mild-to-moderate Covid-19 patients in the US. The company has also recently announced that they have completed the enrollment of 394 patients in its Phase 2b/3 randomized clinical trial for the severe-to-critically ill Covid-19 population.
...
Typical tactics include the following:
Flooding the offer side of the board - Ultimately the price of a stock is found at the balance point where supply (offer) and demand (bid) for the shares find equilibrium. This equation happens every day for every stock traded. On days when more people want to buy than want to sell, the price goes up, and, conversely, when shares offered for sale exceed the demand, the price goes down.
The shorts manipulate the laws of supply and demand by flooding the offer side with counterfeit shares. They will do what has been called a short down ladder. It works as follows: Short A will sell a counterfeit share at $10. Short B will purchase that counterfeit share covering a previously open position. Short B will then offer a short (counterfeit) share at $9. Short A will hit that offer, or short B will come down and hit Short A's $9 bid. Short A buys the share for $9, covering his open $10 short and booking a $1 profit.
By repeating this process the shorts put the stock price in a downward spiral.Massive counterfeiting can drive the stock price down in a matter of hours on extremely high volume. This is called "crashing" the stock and a successful "crash" is a one-day drop of twenty-percent or a thirty-five percent drop in a week. In order to make the crash "stick" or make it more effective, it is done concurrently with all or most of the following:
Media Assault -The shorts, in order to realize their profit, must ultimately put the victim into bankruptcy or obtain shares at a price much cheaper than what they shorted at. These shares come from the investing public who panics and sells into the manipulation. Panic is induced with assistance from the financial media.
The shorts have "friendly" reporters with the Dow Jones News Agency, the Wall Street Journal, Barrons, the New York Times, Gannett Publications (USA Today and the Arizona Republic), CNBC and others. The common thread: A number of the "friendly" reporters worked for The Street.com, an Internet advisory service that short hedge-fund managers David Rocker and Jim Cramer owned. This alumni association supported the short attack by producing slanted, libelous, innuendo laden stories that disparaged the company, as it was being crashed.
One of the more outrageous stories was a front-page story in USA Today during a short crash of TASER's stock price in June 2005. The story was almost a full page and the reporter concluded that TASER's electrical jolt was the same as an electric chair - proof positive that TASERs did indeed kill innocent people. To reach that conclusion the reporter over estimated the TASER's amperage by a factor of one million times. This "mistake" was made despite a detailed technical briefing by TASER to seven USA Today editors two weeks prior to the story. The explanation "Due to a mathematical error" appeared three days later - after the damage was done to the stock price.
Analyst Reports -Some alleged independent analysts were actually paid by the shorts to write slanted negative ratings reports. The reports, which were represented as being independent, were ghost written by the shorts and disseminated to coincide with a short attack. There is congressional testimony in the matter of Gradiant Analytic and Rocker Partners that expands upon this. These libelous reports would then become a story in the aforementioned "friendly" media. All were designed to panic small investors into selling their stock into the manipulation.
Planting moles in target companies -The shorts plant "moles" inside target companies. The moles can be as high as directors or as low as janitors. They steal confidential information, which is fed to the shorts who may feed it to the friendly media. The information may not be true, may be out of context, or the stolen documents may be altered. Things that are supposed to be confidential, like SEC preliminary inquiries, end up as front-page news with the short-friendly media.
Frivolous SEC investigations -The shorts "leak" tips to the SEC about "corporate malfeasance" by the target company. The SEC, which can take months processing Freedom of Information Act requests, swoops in as the supposed "confidential inquiry" is leaked to the short media.
The plethora of corporate rules means the SEC may ultimately find minor transgressions or there may be no findings. Occasionally they do uncover an Enron, but the initial leak can be counted on to drive the stock price down by twenty-five percent. The announcement of no or little findings comes months later, but by then the damage that has been done to the stock price is irreversible. The San Francisco office of the SEC appears to be particularly close to the short community.
Class Action lawsuits -
Based upon leaked stories of SEC investigations or other media exposes, a handful of law firms immediately file class-action shareholder suits. Milberg Weiss, before they were disbanded as a result of a Justice Department investigation, could be counted on to file a class-action suit against a company that was under short attack. Allegations of accounting improprieties that were made in the complaint would be reported as being the truth by the short friendly media, again causing panic among small investors.
Interfering with target company's customers, financings, etc. -
If the shorts became aware of clients, customers or financings that the target company was working on, they would call and tell lies or otherwise attempt to persuade the customer to abandon the transaction. Allegedly the shorts have gone so far as to bribe public officials to dissuade them from using a company's product.
Pulling margin from long customers -
The clearinghouses and broker dealers who finance margin accounts will suddenly pull all long margin availability, citing very transparent reasons for the abrupt change in lending policy. This causes a flood of margin selling, which further drives the stock price down and gets the shorts the cheap long shares that they need to cover. (Click here for more on Pulling Margin).
Paid Shills -
The shorts will hire paid bashers who "invade" the message boards of the company. The bashers disguise themselves as legitimate investors and try to persuade or panic small investors into selling into the manipulation.
(Original confessions of a paid shill 2007 "serpent basher": http://counterfeitingstock.com/CS2.0/CS16ConfessionsOfAPaidStockBasher.html )
copypasta from
https://www.investopedia.com/investing/why-do-companies-care-about-their-stock-prices/:What does stock price do for a company? Why Do Companies Care About Their Stock Prices?
As a rule, the higher a stock price is, the rosier a company’s prospects become.
Financial Health-
Analysts evaluate the trajectory of stock prices in order to gauge a company’s general health. They likewise rely on earning histories, and price-to-earnings (P/E) ratios, which signal whether a company’s share price adequately reflects its earnings. All of this data aids analysts and investors in determining a company’s long-term viability.
A company should be careful not to over-issue new shares, because an overabundance of shares circulating in the market may diminish demand, where there’s simply not enough buyers to gobble up the shares, which could ultimately depress the stock price.
Furthermore, creditors favor companies with higher-priced shares, which typically correlate with a company's earnings. Such healthy companies are better able to pay off long-term debt, which usually means they’ll attract lower-interest-rate loans, which consequently strengthens their balance sheets.
A Performance Indicator of Executive Management -
Investment analysts ritually track a publicly-traded company's stock price in order to gauge a company's fiscal health, market performance, and general viability. A steadily rising share price signals that a company's top brass is steering operations toward profitability.
Furthermore, if shareholders are pleased, and the company is tilting towards success, as indicated by a rising share price, C-level executives are likely to retain their positions with the company. Such senior personnel are also likely to enjoy salary raises and yearly bonuses.
Conversely, if a company is struggling, as reflected by a dwindling share price, a company's board may decide to fire its top operatives. Simply put, falling share prices do not bode well for a company's higher-ups.
Compensation -
Compensation likewise represents a critical rationale for a company's decision-makers to do everything in their power to make sure a corporation's share price thrives. This is because many of those occupying senior management positions derive portions of their overall earnings from stock options. These perks afford management personnel the ability to acquire shares of the corporation at a determined price, on a future set date.
But for the option to increase in worth, the underlying stock price must flourish. For this reason, the existence of stock options is vitally important to stimulating a company's health. Otherwise put, executives stand to personally gain when they make strategic decisions that benefit a company's bottom line, which ultimately helps stockholders grow the value of their portfolios.
Risk of Takeover -The prevention of a takeover is another reason a corporation might be concerned with its stock price. When a company's stock price falls, the likelihood of a takeover increases, mainly due to the fact that the company's market value is cheaper.
Shares in publicly traded companies are typically owned by wide swaths of investors. Therefore, bidders who seek to take over a company by obtaining a majority of shares can more easily afford to do so when the stock is trading at a lower price.
Consequently, management strives to keep the share price high in order to discourage this activity. Conversely, a company whose shares trade for high prices are better positioned to take over a competitive interest.
Positive Press -Companies with high share prices tend to attract positive attention from the media and from equity analysts. The larger a company's market capitalization, the wider the coverage it receives. This has a chain effect of attracting more investors to the company, which infuses it with the cash it relies on to flourish over the long haul.
.
.
my cares:
If CytoDyn wasn't under SEC approved short attacks by CitronResearch in July they could have had their covid cure approved before November, saving millions of lives.
lyingpress unanimously claims that a website everyone reviles (facebook) is worth $750B,
but 5000+ brick and mortar stores (gamestop) must be worth less than $30B
We'll see about that.
disclosure:
I have no $CYDY yet but I will